1 |
BADE B C, DELA CRUZ C S. Lung cancer 2020: epidemiology, etiology, and prevention[J]. Clin Chest Med, 2020, 41(1): 1-24.
|
2 |
MARCINKOWSKI B, STEVANOVIĆ S, HELMAN S R,et al. Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu lung cancer antigen-1[J]. J Immunother Cancer, 2019, 7(1): 229.
|
3 |
BALZER B W R, LOO C, LEWIS C R, et al. Adenocarcinoma of the lung in childhood and adolescence: a systematic review[J]. J Thorac Oncol, 2018, 13(12): 1832-1841.
|
4 |
WANG Q H, LI M L, YANG M, et al. Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy[J]. Aging, 2020, 12(4): 3312-3339.
|
5 |
QIU Y S, LIAO G J, JIANG N N. DNA methylation-mediated silencing of regenerating protein 1 alpha (REG1A) affects gastric cancer prognosis[J]. Med Sci Monit, 2017, 23: 5834-5843.
|
6 |
ZHAO Z T, LI Y, YUAN H Y, et al. Identification of key genes and pathways in gastric signet ring cell carcinoma based on transcriptome analysis[J]. World J Clin Cases, 2020, 8(4): 658-669.
|
7 |
周群燕, 葛洪超, 李雅琳, 等. 胃癌中Reg1α和STAT3的表达水平与临床特征的关系[J]. 国际消化病杂志, 2018, 38(6): 418-421.
|
8 |
XING H J, CHEN X D, SUN H X, et al. Association of regenerating gene 1A single-nucleotide polymorphisms and nasopharyngeal carcinoma susceptibility in southern Chinese population[J]. Eur Arch Otorhinolaryngol, 2020, 277(1): 221-226.
|
9 |
GENG J, FAN J, WANG Q, et al. Decreased REG1α expression suppresses growth, invasion and angiogenesis of bladder cancer[J].Eur J Surg Oncol,2017,43(4):837-846.
|
10 |
DEBERNARDI S, ÓBRIEN H, ALGAHMDI A S,et al. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: a case-control study[J].PLoS Med,2020,17(12):e1003489.
|
11 |
MINAMIYA Y, KAWAI H, SAITO H, et al. REG1A expression is an independent factor predictive of poor prognosis in patients with non-small cell lung cancer[J]. Lung Cancer, 2008, 60(1): 98-104.
|
12 |
DOWNING S, ZHANG F, CHEN Z J, et al. microRNA-7 directly targets Reg1 in pancreatic cells[J]. Am J Physiol Cell Physiol, 2019, 317(2): C366-C374.
|
13 |
ZHANG Y M, YUAN X L, ZHU X Y, et al. Serum REG Iα as a potential novel biomarker in cancer[J]. Medicine, 2020, 99(38): e22281.
|
14 |
MAO H L, JIA J L, SHENG J X, et al. Protective and anti-inflammatory role of REG1A in inflammatory bowel disease induced by JAK/STAT3 signaling axis[J]. Int Immunopharmacol, 2021, 92: 107304.
|
15 |
SAID S, KURTIN P J, NASR S H, et al. Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma[J]. Hum Pathol, 2020, 103: 120-126.
|
16 |
SASAKI Y, MINAMIYA Y, TAKAHASHI N, et al. REG1A expression is an independent factor predictive of poor prognosis in patients with breast cancer[J]. Ann Surg Oncol, 2008, 15(11): 3244-3251.
|
17 |
KIMURA M, NAITO H, TOJO T, et al. REG Iα gene expression is linked with the poor prognosis of lung adenocarcinoma and squamous cell carcinoma patients via discrete mechanisms[J]. Oncol Rep, 2013, 30(6): 2625-2631.
|
18 |
ASTROSINI C, ROEEFZAAD C, DAI Y Y, et al. REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis[J]. Int J Cancer, 2008, 123(2): 409-413.
|
19 |
SEKIKAWA A, FUKUI H, FUJII S, et al. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells[J]. Carcinogenesis, 2008, 29(1): 76-83.
|
20 |
KRISHNAMURTHY N, KURZROCK R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors[J]. Cancer Treat Rev, 2018, 62: 50-60.
|
21 |
FAROOQI A A, MUKHANBETZHANOVNA A A, YILMAZ S, et al. Mechanistic role of DANCR in the choreography of signaling pathways in different cancers: spotlight on regulation of Wnt/β-catenin and JAK/STAT pathways by oncogenic long non-coding RNA[J]. Noncoding RNA Res, 2021, 6(1): 29-34.
|
22 |
WANG Z, LI Z L, JI H T. Direct targeting of β-catenin in the Wnt signaling pathway: current progress and perspectives[J]. Med Res Rev, 2021, 41(4):2109-2129.
|
23 |
XU H, JIAO X G, WU Y L, et al. Exosomes derived from PM2.5treated lung cancer cells promote the growth of lung cancer via the Wnt3a/βcatenin pathway[J]. Oncol Rep, 2019, 41(2): 1180-1188.
|
24 |
PAN J, FANG S, TIAN H, et al. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling[J]. Mol Cancer, 2020, 19(1): 9.
|
25 |
CHANVORACHOTE P, SRIRATANASAK N, NONPANYA N. C-myc contributes to malignancy of lung cancer: a potential anticancer drug target[J]. Anticancer Res, 2020, 40(2): 609-618.
|
26 |
SHA Y L, LIU S, YAN W W, et al. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma[J].Biosci Rep,2019,39(9):BSR20192466.
|
27 |
CAVARD C, TERRIS B, GRIMBER G, et al. Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations[J]. Oncogene, 2006,25(4): 599-608.
|